Melior Discovery: Melior Is Recognized as CRO of the Year by Life Sciences Review

EXTON, Pa.--(BUSINESS WIRE)-- #CRO--Melior Discovery, Inc. (Melior) announced today that it has been selected as the CRO of the Year by Life Sciences Review magazine. The year-end edition of the magazine is dedicated to coverage of 10 preeminent CROs, among which Melior was selected as CRO of the Year. The recognition focused on Melior's unique offering within the pre-clinical pharmacology space with its phenotypic screening platform theraTRACE®, as well as its related offerings in the oncology space